Literature DB >> 29419443

Inhaled granulocyte-macrophage colony-stimulating factor for Mycobacterium abscessus in cystic fibrosis.

John P Scott1, Yinduo Ji2, Mathur Kannan2, Mark E Wylam3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29419443     DOI： 10.1183/13993003.02127-2017

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  14 in total

1.  Aerosol granulocyte macrophage-colony stimulating factor: a low toxicity, lung-specific biological therapy in patients with lung metastases.

Authors:  P M Anderson; S N Markovic; J A Sloan; M L Clawson; M Wylam; C A Arndt; W A Smithson; P Burch; M Gornet; E Rahman
Journal:  Clin Cancer Res       Date:  1999-09       Impact factor: 12.531

2.  Fatal pulmonary infection due to multidrug-resistant Mycobacterium abscessus in a patient with cystic fibrosis.

Authors:  M Sanguinetti; F Ardito; E Fiscarelli; M La Sorda ; P D'Argenio; G Ricciotti; G Fadda
Journal:  J Clin Microbiol       Date:  2001-02       Impact factor: 5.948

3.  Lung transplantation in patients with cystic fibrosis and Mycobacterium abscessus infection.

Authors:  Marita Gilljam; Henrik Scherstén; Martin Silverborn; Bodil Jönsson; Annika Ericsson Hollsing
Journal:  J Cyst Fibros       Date:  2010-04-18       Impact factor: 5.482

4.  Cytokine concentrations in sputum from patients with cystic fibrosis and their relation to eosinophil activity.

Authors:  D Y Koller; I Nething; J Otto; R Urbanek; I Eichler
Journal:  Am J Respir Crit Care Med       Date:  1997-03       Impact factor: 21.405

5.  Release of interleukin-8, interleukin-6, and colony-stimulating factors by upper airway epithelial cells: implications for cystic fibrosis.

Authors:  M Bédard; C D McClure; N L Schiller; C Francoeur; A Cantin; M Denis
Journal:  Am J Respir Cell Mol Biol       Date:  1993-10       Impact factor: 6.914

6.  Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma.

Authors:  K L Woolley; E Adelroth; M J Woolley; R Ellis; M Jordana; P M O'Byrne
Journal:  Eur Respir J       Date:  1994-09       Impact factor: 16.671

7.  Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.

Authors:  Megan N Ballinger; Robert Paine; Carlos H C Serezani; David M Aronoff; Esther S Choi; Theodore J Standiford; Galen B Toews; Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

8.  Macrophages directly contribute to the exaggerated inflammatory response in cystic fibrosis transmembrane conductance regulator-/- mice.

Authors:  Emanuela M Bruscia; Ping-Xia Zhang; Elisa Ferreira; Christina Caputo; John W Emerson; David Tuck; Diane S Krause; Marie E Egan
Journal:  Am J Respir Cell Mol Biol       Date:  2008-09-05       Impact factor: 6.914

9.  Bacterial stimulation of epithelial G-CSF and GM-CSF expression promotes PMN survival in CF airways.

Authors:  Shahryar Saba; Grace Soong; Steven Greenberg; Alice Prince
Journal:  Am J Respir Cell Mol Biol       Date:  2002-11       Impact factor: 6.914

10.  GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus.

Authors:  Mary Ann De Groote; Laura Johnson; Brendan Podell; Elizabeth Brooks; Randall Basaraba; Mercedes Gonzalez-Juarrero
Journal:  J Antimicrob Chemother       Date:  2013-11-11       Impact factor: 5.790
View more
  8 in total

Review 1.  Advances in bronchiectasis: endotyping, genetics, microbiome, and disease heterogeneity.

Authors:  Patrick A Flume; James D Chalmers; Kenneth N Olivier
Journal:  Lancet       Date:  2018-09-08       Impact factor: 79.321

2.  Tissue-localized immune responses in people with cystic fibrosis and respiratory nontuberculous mycobacteria infection.

Authors:  Don Hayes; Rajni Kant Shukla; Yizi Cheng; Emrah Gecili; Marlena R Merling; Rhonda D Szczesniak; Assem G Ziady; Jason C Woods; Luanne Hall-Stoodley; Namal Pm Liyanage; Richard T Robinson
Journal:  JCI Insight       Date:  2022-06-22

Review 3.  An Update in Antimicrobial Therapies and Infection Prevention in Pediatric Lung Transplant Recipients.

Authors:  O C Smibert; M A Paraskeva; G Westall; Greg Snell
Journal:  Paediatr Drugs       Date:  2018-12       Impact factor: 3.022

Review 4.  What lies beneath the airway mucosal barrier? Throwing the spotlight on antigen-presenting cell function in the lower respiratory tract.

Authors:  Saparna Pai; Visai Muruganandah; Andreas Kupz
Journal:  Clin Transl Immunology       Date:  2020-07-23

5.  Inhaled GM-CSF in neonatal mice provides durable protection against bacterial pneumonia.

Authors:  Elizabeth M Todd; Rashmi Ramani; Taylor P Szasz; S Celeste Morley
Journal:  Sci Adv       Date:  2019-08-14       Impact factor: 14.136

6.  Mycobacterium abscessus biofilms have viscoelastic properties which may contribute to their recalcitrance in chronic pulmonary infections.

Authors:  Erin S Gloag; Daniel J Wozniak; Paul Stoodley; Luanne Hall-Stoodley
Journal:  Sci Rep       Date:  2021-03-03       Impact factor: 4.379

Review 7.  Sepsis and Nosocomial Infection: Patient Characteristics, Mechanisms, and Modulation.

Authors:  Scott J Denstaedt; Benjamin H Singer; Theodore J Standiford
Journal:  Front Immunol       Date:  2018-10-23       Impact factor: 7.561

Review 8.  The Rise of Non-Tuberculosis Mycobacterial Lung Disease.

Authors:  Champa N Ratnatunga; Viviana P Lutzky; Andreas Kupz; Denise L Doolan; David W Reid; Matthew Field; Scott C Bell; Rachel M Thomson; John J Miles
Journal:  Front Immunol       Date:  2020-03-03       Impact factor: 7.561
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.